RESÚMENES FEBRERO 2008

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Incidence of childhood-onset bipolar illness in the USA and Europe

Robert M. Post, David A. Luckenbaugh, Gabriele S. Leverich, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Paul E. Keck, Susan L. McElroy, Willem A. Nolen, Ralph Kupka, Heinz Grunze, Joerg Walden

The British Journal of Psychiatry (2008) 192: 150-151

3 - Childhood and adulthood socio-economic position and midlife depressive and anxiety disorders

Stephen A. Stansfeld, Charlotte Clark, Bryan Rodgers, Tanya Caldwell, Chris Power

The British Journal of Psychiatry (2008) 192: 152-153

3! - Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder

Jay C. Fournier, Robert J. DeRubeis, Richard C. Shelton, Robert Gallop, Jay D. Amsterdam, Steven D. Hollon

The British Journal of Psychiatry (2008) 192: 124-129

5 - Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes

Mauricio Tohen, Charles L. Bowden, Anatoly B. Smulevich, Richard Bergstrom, Tonya Quinlan, Olawale Osuntokun, Wei V. Wang, Heather S. Oliff, Ferenc Martenyi, Ludmila A. Kryzhanovskaya, Waldemar Greil

The British Journal of Psychiatry (2008) 192: 135-143

3 - The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults

Hayden B. Bosworth, Corrine I. Voils, Guy G. Potter, David C. Steffens

International Journal of Geriatric Psychiatry. Volume 23, Issue 2, Pages 129 - 134

 

3 - The prevalence of panic disorder in pregnant women during the third trimester of pregnancy

Ozkan Guler, Figen Kir Sahin, H. Murat Emul, Omer Ozbulut, Omer Gecici, Faruk Uguz, Kazim Gezginc, Ismet Esra Zeytinci, Savas Karatayli and Rustem Askin

Comprehensive Psychiatry. Volume 49, Issue 2, March-April 2008, Pages 154-158

 

3 - Anatomy and physiology of the basal ganglia: Implications for DBS in psychiatry

Brian Harris Kopell and Benjamin D. Greenberg

Neuroscience & Biobehavioral Reviews. Volume 32, Issue 3, 2008, Pages 408-422

3 - Are benzodiazepines really anxiolytic. Evidence from a 3D maze spatial navigation task

A. Ennaceur, S. Michalikova, R. van Rensburg and P.L. Chazot

Behavioural Brain Research. Volume 188, Issue 1, 17 March 2008, Pages 136-153

 

3 - Serum concentrations of venlafaxine and its metabolites O -desmethylvenlafaxine and N -desmethylvenlafaxine in heterozygous carriers of the CYP2D6 * 3, * 4 or * 5 allele

Pharmacogenetics

Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele

M. Hermann, M. Hendset, K. Fosaas, M. Hjerpset and H. Refsum

European Journal of Clinical Pharmacology. February 2008, Online

 

3! - Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test

Todd D. Gould, Kelley C. O'Donnell, Eliot R. Dow, Jing Du, Guang Chen and Husseini K. Manji

Neuropharmacology. Volume 54, Issue 3, March 2008, Pages 577-587

 

3 - The psychophysiology of generalized anxiety disorder: 1. Pretreatment characteristics
Ansgar Conrad, Linda Isaac, Walton T. Roth
Psychophysiology (OnlineEarly Articles). February 2008

3! - Depression and Ischemic Heart Disease Mortality: Evidence From the EPIC-Norfolk United Kingdom Prospective Cohort Study

Paul G. Surtees, Nicholas W.J. Wainwright, Robert N. Luben, Nicholas J. Wareham, Sheila A. Bingham, and Kay-Tee Khaw

Am J Psychiatry Published February 1, 2008

5 - Augmentation of Behavior Therapy With D-Cycloserine for Obsessive-Compulsive Disorder

Sabine Wilhelm, Ulrike Buhlmann, David F. Tolin, Suzanne A. Meunier, Godfrey D. Pearlson, Hannah E. Reese, Paul Cannistraro, Michael A. Jenike, and Scott L. Rauch

Am J Psychiatry Published February 1, 2008

3! - CRH1 Receptor Antagonists for the Treatment of Depression and Anxiety

Marcus Ising and Florian Holsboer

Experimental and Clinical Psychopharmacology. Volume 15, Issue 6, December 2007, Pages 519-528

 

3 - Testosterone Supplementation for Depressed Men: Current Research and Suggested Treatment Guidelines

Gen Kanayama, Revital Amiaz, Stuart Seidman and Harrison G. Pope Jr.

Experimental and Clinical Psychopharmacology. Volume 15, Issue 6, December 2007, Pages 529-538

 

3 - The prevalence of mixed episodes during the course of illness in bipolar disorder
L. V. Kessing
Acta Psychiatrica Scandinavica 2008; 117 (3), 216–224

3! - Higher Burden of Depression Among Older Women. The Effect of Onset, Persistence, and Mortality Over Time

Lisa C. Barry, Heather G. Allore, Zhenchao Guo, Martha L. Bruce, Thomas M. Gill

Arch Gen Psychiatry. 2008;65(2):172-178

 

3! - Influence of Child Abuse on Adult Depression. Moderation by the Corticotropin-Releasing Hormone Receptor Gene

Rebekah G. Bradley, Elisabeth B. Binder, Michael P. Epstein, Yilang Tang, Hemu P. Nair, Wei Liu, Charles F. Gillespie, Tiina Berg, Mark Evces, D. Jeffrey Newport, Zachary N. Stowe, Christine M. Heim, Charles B. Nemeroff, Ann Schwartz, Joseph F. Cubells, Kerry J. Ressler

Arch Gen Psychiatry. 2008;65(2):190-200

 

3 - Quetiapine monotherapy for bipolar depression

Michael E Thase

Neuropsychiatric Disease and Treatment. On-Line Early. February 2008

 

3! - Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder

Triin Eller, Veiko Vasar, Jakov Shlik and Eduard Maron

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 2, 15 February 2008, Pages 445-450

 

3 - Effect of levetiracetam on depression and anxiety in adult epileptic patients

Marianna Mazza, Annalisa Martini, Marta Scoppetta and Salvatore Mazza

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 2, 15 February 2008, Pages 539-543

 

3! - Platelet serotonin concentration and suicidal behavior in combat related posttraumatic stress disorder

Zrnka Kovacic, Neven Henigsberg, Nela Pivac, Gordana Nedic and Andrea Borovecki

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 2, 15 February 2008, Pages 544-551

 

5! - Double-Blind, Randomized Comparison of Memantine and Escitalopram for the Treatment of Major Depressive Disorder Comorbid With Alcohol Dependence

Leea H. Muhonen, Jouko Lönnqvist, Kati Juva, and Hannu Alho

J Clin Psychiatry February 6, 2008: e1-e8

 

3 - A Pilot Study of Cranial Electrotherapy Stimulation for Generalized Anxiety Disorder

Alexander Bystritsky, Lauren Kerwin, and Jamie Feusner

J Clin Psychiatry February 6, 2008: e1-e6

 

5 - Paroxetine CR Augmentation for Posttraumatic Stress Disorder Refractory to Prolonged Exposure Therapy

Naomi M. Simon, Kathryn M. Connor, Ariel J. Lang, Sheila Rauch, Stan Krulewicz, Richard T. LeBeau, Jonathan R. T. Davidson, Murray B. Stein, Michael W. Otto, Edna B. Foa, and Mark H. Pollack

J Clin Psychiatry February 6, 2008: e1-e6

 

3! - What is the optimal serum lithium level in the long-term treatment of bipolar disorder - a review?
WE Severus, N Kleindienst, F Seemüller, S Frangou, HJ Möller, W Greil

Bipolar Disorders 2008; 10 (2), 231–237

 

3 - Clinical predictors of unrecognized bipolar I and II disorders
Outi Mantere, Kirsi Suominen, Petri Arvilommi, Hanna Valtonen, Sami Leppämäki, Erkki Isometsä

Bipolar Disorders 2008; 10 (2), 238–244

 

3! - Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction
Carmen Simonsen, Kjetil Sundet, Anja Vaskinn, Astrid B Birkenaes, John A Engh, Charlotte Fredslund Hansen, Halldóra Jónsdóttir, Petter Andreas Ringen, Stein Opjordsmoen, Svein Friis, Ole A Andreassen

Bipolar Disorders 2008; 10 (2), 245–255

 

3 - Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients
Paola Salvatore, Stefano Ghidini, Gianmaria Zita, Chiara De Panfilis, Samuele Lambertino, Carlo Maggini, Ross J Baldessarini

Bipolar Disorders 2008; 10 (2), 256–265

 

4! - Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials
Joseph R Calabrese, Russell F Huffman, Robin L White, Suzanne Edwards, Thomas R Thompson, John A Ascher, Eileen T Monaghan, Robert A Leadbetter

Bipolar Disorders 2008; 10 (2), 323–333

 

3 - Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder
Ruud van Winkel, Marc De Hert, Dominique Van Eyck, Linda Hanssens, Martien Wampers, Andre Scheen, Joseph Peuskens

Bipolar Disorders 2008; 10 (2), 342–348

 

3! - Long-term suicide risk of depression in the Lundby cohort 1947-1997 - severity and gender
L. Brådvik, C. Mattisson, M. Bogren, P. Nettelbladt

Acta Psychiatrica Scandinavica 2008; 117 (3), 185–191

 

3! - The prevalence of mixed episodes during the course of illness in bipolar disorder
L. V. Kessing

Acta Psychiatrica Scandinavica 2008; 117 (3), 216–224

 

4 - Differential Antidepressant Symptom Efficacy: Placebo-Controlled Comparisons of Duloxetine and SSRIs (Fluoxetine, Paroxetine, Escitalopram)
Craig H. Mallinckrodt, Apurva Prakash, John P. Houston, Ralph Swindle, Michael J. Detke, Maurizio Fava

Neuropsychobiology 2007;56:73-85

 

3! - Timing of Clinical Improvement and Symptom Resolution in the Treatment of Major Depressive Disorder. A Replication of Findings with the Use of a Double-Blind, Placebo-Controlled Trial of Hypericum perforatum versus Fluoxetine
George I. Papakostas, Christine M. Crawford, Margaret J. Scalia, Maurizio Fava
Neuropsychobiology 2007;56:132-137

 

5 - No Effect of 5-Day Treatment with Acetylsalicylic Acid (Aspirin) or the Beta-Blocker Propranolol (Inderal) on Free Cortisol Responses to Acute Psychosocial Stress: A Randomized Double-Blind, Placebo-Controlled Study
Brigitte M. Kudielka, Joachim E. Fischer, Petra Metzenthin, Susanne Helfricht, Daniel Preckel, Roland von Känel
Neuropsychobiology 2007;56:159-166

 

3 - Twelve-year depressive symptom trajectories and their predictors in a community sample of older adults

Carmen Andreescu, Chou-Chung H. Chang, Benoit H. Mulsant and Mary Ganguli

International Psychogeriatrics (2008), 20:221-236

 

4 - Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder

Joel Raskin, Jimmy Y. Xu and Daniel K. Kajdasz

International Psychogeriatrics (2008), 20:309-327

 

3! - OCD with comorbid OCPD: A subtype of OCD?

Meredith E. Coles, Anthony Pinto, Maria C. Mancebo, Steven A. Rasmussen and Jane L. Eisen

Journal of Psychiatric Research. Volume 42, Issue 4, March 2008, Pages 289-296

 

3! - Exposure to bright light is associated with positive social interaction and good mood over short time periods: A naturalistic study in mildly seasonal people

M. aan het Rot, D.S. Moskowitz and S.N. Young

Journal of Psychiatric Research. Volume 42, Issue 4, March 2008, Pages 311-319

 

3 - The effects of pentazocine, a kappa agonist, in patients with mania

Bruce M. Cohen and Beth Murphy

The International Journal of Neuropsychopharmacology (2008), 11:243-247

 

5 - A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression

Paulo S. Boggio, Sergio P. Rigonatti, Rafael B. Ribeiro, Martin L. Myczkowski, Michael A. Nitsche, Alvaro Pascual-Leone and Felipe Fregni

The International Journal of Neuropsychopharmacology (2008), 11:249-254

 

3 - Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea

Misuzu Tanaka, Daisuke Kobayashi, Yuko Murakami, Norio Ozaki, Tatsuyo Suzuki, Nakao Iwata, Koichi Haraguchi, Ichiro Ieiri, Naoko Kinukawa, Masako Hosoi, Hisakazu Ohtani, Yasufumi Sawada and Kazunori Mine

The International Journal of Neuropsychopharmacology (2008), 11:261-267

 

3! - A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?

Konstantinos N. Fountoulakis, Eduard Vieta, Constantin Bouras, Grigorios Notaridis, Panteleimon Giannakopoulos, George Kaprinis and Hagop Akiskal

The International Journal of Neuropsychopharmacology (2008), 11:269-287

 

GRATIS (require registro) 3 - Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?

Maurizio Pompili, Marco Innamorati, Michele Raja, Ilaria Falcone, Giuseppe Ducci, Gloria Angeletti, David Lester, Paolo Girardi, Roberto Tatarelli, Eleonora De Pisa

Neuropsychiatric Disease and Treatment. On-Line Early. February 2008

 

3! - Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

Williams, Lana J; Henry, Margaret J; Berk, Michael; Dodd, Seetal; Jacka, Felice N; Kotowicz, Mark A; Nicholson, Geoffrey C; Pasco, Julie A

International Clinical Psychopharmacology. 23(2):84-87, March 2008

3 - Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients

Malempati, Rao N; Bond, David J; Yatham, Lakshmi N

International Clinical Psychopharmacology. 23(2):88-94, March 2008

3! - Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

Sclar, David A; Robison, Linda M; Skaer, Tracy L

International Clinical Psychopharmacology. 23(2):106-109, March 2008

2 - Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series

Oulis, Panagiotis; Masdrakis, Vasilios G.; Karakatsanis, Nikolaos A.; Karapoulios, Evangelos; Kouzoupis, Anastasios V.; Konstantakopoulos, George; Soldatos, Constantin R

International Clinical Psychopharmacology. 23(2):110-112, March 2008

GRATIS (require registro) 3 - Preliminary effects of pagoclone, a partial GABAA agonist, on neuropsychological performance

Angela F Caveney, Bruno Giordani, George M Haig

Neuropsychiatric Disease and Treatment. On-Line Early. February 2008

 

GRATIS (require registro) 3 - Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran

Naghmeh Mokhber, Carol J Lane, Mohamad R Azarpazhooh, Elham Salari, Reza Fayazi, Mohamad T Shakeri, Allan H Young

Neuropsychiatric Disease and Treatment. On-Line Early. February 2008

 

3! - The Efficacy of Acute ECT in Atypical Depression

Mustafa M. Husain, Shawn M. McClintock, A. John Rush, Rebecca G. Knapp, Max Fink, Teresa A. Rummans, Keith Rasmussen, Cynthia Claassen, Georgios Petrides, Melanie M. Biggs, Martina Mueller, Shirlene Sampson, Samuel H. Bailine, Sarah H. Lisanby, and Charles H. Kellner

J Clin Psychiatry February 13, 2008: e1-e6

 

5 - Placebo-Controlled Trial of Risperidone Augmentation for Selective Serotonin Reuptake Inhibitor-Resistant Civilian Posttraumatic Stress Disorder

Barbara O. Rothbaum, Therese K. Killeen, Jonathan R. T. Davidson, Kathleen T. Brady, Kathryn M. Connor, and Mary H. Heekin

J Clin Psychiatry February 13, 2008: e1-e6

 

3! - Risks of Suicide and Poisoning Among Elderly Patients Prescribed Selective Serotonin Reuptake Inhibitors: A Retrospective Cohort Study

Elham Rahme, Kaberi Dasgupta, Gustavo Turecki, Hacene Nedjar, and Guillaume Galbaud du Fort

J Clin Psychiatry February 13, 2008: e1-e9

 

5 - A Randomized-Controlled Trial of Bilateral rTMS for Treatment-Resistant Depression

Paul B. Fitzgerald

Progress in Neurotherapeutics and Neuropsychopharmacology (2008), 3: 211-226

 

3 - Serotonin Related Genes Affect Antidepressant Treatment in Obsessive–Compulsive Disorder

F. Van Nieuwerburgh, D. Deforce and D.A.J.P. Denys

Progress in Neurotherapeutics and Neuropsychopharmacology (2008), 3: 227-240

 

5 - Pharmacotherapy for social anxiety disorder: a systematic review

Jonathan C Ipser, Catherine M Kariuki and Dan J Stein

Expert Review of Neurotherapeutics. February 2008, Vol. 8, No. 2, Pages 235-257

 

GRATIS 3 - Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states)

Franco Benazzi

European Psychiatry. Volume 23, Issue 1, January 2008, Pages 40-48

 

GRATIS 3 - Electroconvulsive therapy in the treatment of mixed states in bipolar disorder

Marc Valentí, Antoni Benabarre, Margarita García-Amador, Oriol Molina, Miquel Bernardo and Eduard Vieta

European Psychiatry. Volume 23, Issue 1, January 2008, Pages 53-56

 

GRATIS 3 - Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study

Michael Bauer, Brigitta U. Monz, Angel L. Montejo, Deborah Quail, Nicolas Dantchev, Koen Demyttenaere, Ana Garcia-Cebrian, Luigi Grassi, David G.S. Perahia, Catherine Reed and Andre Tylee

European Psychiatry. Volume 23, Issue 1, January 2008, Pages 66-73

 

GRATIS 5< - Transcranial direct stimulation and fluoxetine for the treatment of depression

Sergio P. Rigonatti, Paulo S. Boggio, Martin L. Myczkowski, Emma Otta, Juliana T. Fiquer, Rafael B. Ribeiro, Michael A. Nitsche, Alvaro Pascual-Leone and Felipe Fregni

European Psychiatry. Volume 23, Issue 1, January 2008, Pages 74-76

 

3! - Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D

Original Article

Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D

Bradley N. Gaynes, A. John Rush, Madhukar H. Trivedi, Stephen R. Wisniewski, G.KBalasubramani, Patrick J. McGrath, Michael E. Thase, Michael Klinkman, Andrew A. Nierenberg, William R. Yates and Maurizio Fava

Journal of General Internal Medicine; On-Line First. February 2008

 

3 - Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression
Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Young-Chul Kim, Kyu-Sik Kim, Ki-Min Kim, Su-Jin Yang, Jin-Sang Yoon

Psychiatry and Clinical Neurosciences 2008; 62 (1), 75–83

 

3 - Six-month paroxetine treatment of premenstrual dysphoric disorder: Continuous versus intermittent treatment protocols
Kuan-Yi Wu, Chia-Yih Liu, Mei-Chun Hsiao

Psychiatry and Clinical Neurosciences 62 (1), 109–114

 

3! - Serotonin transporter polymorphism and bleeding time during SSRI therapy
Dahlia M. C. Hougardy, Toine C. G. Egberts, Fedde van der Graaf, Vincent J. Brenninkmeijer, Luc J. J. Derijks
British Journal of Clinical Pharmacology. On-Line Early. February 2008

 

3 - Antidepressant drugs and memory: Insights from animal studies

Santiago Monleón, Concepción Vinader-Caerols, M. Carmen Arenas and Andrés Parra

European Neuropsychopharmacology. Volume 18, Issue 4, April 2008, Pages 235-248

 

GRATIS 3! - Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management

Nelson LS, Erdman AR, Booze LL, Cobaugh DJ, Chyka PA, Woolf AD, Scharman EJ, Wax PM, Manoguerra AS, Christianson G, Caravati EM, Troutman WG

Clin Toxicol (Phila) 2007 May;45(4):315-32

 

GRATIS 3! - Suicidality and Antiepileptic Drugs

Information for Healthcare Professionals

FDA ALERT [1/31/2008]

 

5 - Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study

Fabiano G. Nery, Emel S. Monkul, John P. Hatch, Manoela Fonseca, Giovana B. Zunta-Soares, Benício N. Frey, Charles L. Bowden, Jair C. Soares

Human Psychopharmacology: Clinical and Experimental. Volume 23, Issue 2, Pages 87 - 94

 

3 - Factors associated with treatment